Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Clinical trial NCT00764634 · COMPLETED

Trial details

NCT number: NCT00764634
Sponsor: DynPort Vaccine Company LLC, A GDIT Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Botulism Vaccine

Start date: 2008-09-01
Primary completion: 2010-03-01
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.